Page 17 - Curevac Vakzine According News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Curevac vakzine according. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Curevac Vakzine According Today - Breaking & Trending Today

DGAP-News: CureVac Announces Changes of CDO - Myriam Mendila to succeed Klaus Edvardsen Seite 1

08.06.2022 - Issuer: CureVac / Key word(s): Personnel CureVac Announces Changes of CDO - Myriam Mendila to succeed Klaus Edvardsen 08.06.2022 / 22:05 The issuer is solely responsible for the content of this announcement. CureVac Announces Changes of CDO - . Seite 1 ....

United States , Klaus Edvardsen , Ulrike Gnad Vogt , Myriam Mendila , Franz Werner Haas , Development Officer , Chief Development Officer , Senior Vice President Area Head Oncology , Chief Development Officer Klaus Edvardsen , Senior Vice President Area Head , Chief Development , Werner Haas , Gap News ,

CureVac Buys Frame Cancer Therapeutics

(PLX AI) - CureVac buys Frame Cancer Therapeutics, a private company focused on advanced genomics and bioinformatics to identify both unique and shared neoantigens across different cancer types.• Acquisition ....

Frame Cancer Therapeutics ,

Investegate |CureVac Announcements | CureVac: CureVac Announces Changes of CDO - Myriam Mendila to succeed Klaus Edvardsen

Investegate announcements from CureVac, CureVac Announces Changes of CDO - Myriam Mendila to succeed Klaus Edvardsen ....

United States , Baden Wüberg , Klaus Edvardsen , Ulrike Gnad Vogt , Merck Kga , Myriam Mendila , Sarah Fakih , Franz Werner Haas , Development Officer , National Center , University Of Homburg Saar , University Of Hanover , Head Of Clinical Development , Corporate Communications , Worldwide Head Of Medical Affairs , Curevac Announces Changes , Chief Development Officer , Senior Vice President Area Head Oncology , Chief Development , Chief Development Officer Klaus Edvardsen , Werner Haas , Supervisory Board , Worldwide Head , Medical Affairs , Chief Medical Officer Oncology , Novartis Pharma ,

DGAP-News: CureVac Accelerates Oncology Strategy with Acquisition of Frame Cancer Therapeutics, Adding Novel Antigen Discovery Platform Seite 1

08.06.2022 - Issuer: CureVac / Key word(s): Takeover CureVac Accelerates Oncology Strategy with Acquisition of Frame Cancer Therapeutics, Adding Novel Antigen Discovery Platform 08.06.2022 / 22:10 The issuer is solely responsible for the content of this . Seite 1 ....

Franz Werner Haas , Frame Cancer Therapeutics , Chief Executive Officer , Gap News ,

CureVac's (CVAC) "Buy" Rating Reiterated at JMP Securities

CureVac (NASDAQ:CVAC – Get Rating)‘s stock had its “buy” rating reaffirmed by research analysts at JMP Securities in a research report issued on Thursday, TipRanks reports. They currently have a $37.00 price target on the stock. JMP Securities’ target price points to a potential upside of 107.40% from the company’s current price. Separately, Zacks Investment […] ....

Lombard Odier Scm , Ltd Zurich , Advisor Group Holdings Inc , Zacks Investment Research , Quadrant Capital Group , Bank Julius Baer Co , Get Rating , Capital Group , Group Holdings , Julius Baer , Compagnie Lombard Odier , Lombard Odier , Nasdaq Cvac , Reiterated Rating , Jmp Securities ,